Loading...
Accelerated Aging And Healthcare Reforms Will Spark Immunotherapy Breakthroughs
AnalystHighTarget's Fair Value
€2.60
49.2% undervalued intrinsic discount11 Sep
€1.32
1Y
30.7%7D
11.4%1Y
30.7%7D
11.4%You can edit this narrative until Aug 13 9:14 PM. Then, changes will post as Updates.